AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
DELAMANID
7 registrations across 5 African markets— 7 active
Markets with DELAMANID
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| DEMTIBI TABLETS | 🇬🇭Ghana | — | active | Jul 2030 |
| DEMTIBI TABLETS | 🇬🇭Ghana | — | active | Jul 2030 |
| DEMTIBI TABLET, COATED; ORAL | 🇿🇼Zimbabwe | MYLAN LABORATORIES LIMITED | active | Jun 2030 |
| DELTYBA | 🇿🇦South Africa | Viatris Healthcare (Pty) Ltd | active | Nov 2029 |
| Delamanid | 🌍WW | Matrix Pharmacorp Private Limited | active | — |
| DEMTIBI Film Coated Tablet | 🇹🇿Tanzania | Mylan Laboratories Limited | active | — |
| Delamanid Tablet, Film-coated 50mg Tablet, Film-coated | 🌍WW | Mylan Laboratories Ltd. | active | — |
DELAMANID in Africa — Regulatory Overview
DELAMANID is registered across 5 African markets with 7 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Ghana, WW, Tanzania, South Africa and 1 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 7 registrations, 7 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.